Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02763384
Title BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

refractory T lymphoblastic leukemia/lymphoma

T-cell adult acute lymphocytic leukemia

Therapies

BKT140 + Nelarabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.